<DOC>
	<DOCNO>NCT00188604</DOCNO>
	<brief_summary>The primary objective study ass effectiveness selenium compare placebo reduce lymphedema in-patients breast cancer . Secondary objective assess impact selenium patient 's quality life ass incidence adverse effect selenium therapy .</brief_summary>
	<brief_title>The Use Selenium Treat Secondary Lymphedema - Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Selenious Acid</mesh_term>
	<mesh_term>Sodium Selenite</mesh_term>
	<criteria>patient clinically document lymphedema upper limb secondary breast cancer management ( surgery axillary nodal dissection , radiotherapy ) patient modality management include , e.g . physical therapy , pharmacological therapy ECOG performance 02 informed consent active cellulitis/skin infection limb venous thrombosis upper limb active malignancy medical condition congenital traumatic injury involve either limb patient already selenium medication patient participate another clinical study relate lymphedema</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>